Covered recipient · General Payments record
EBRAHIM SADIGHIM
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$6,541.51
- Reported across 123 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $656.38 | 9 |
| Education | $169.99 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $331.85 | 5 |
| Abbott Laboratories | $275.00 | 2 |
| Astellas Pharma US Inc | $169.99 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.21 | 1 |
| ABBVIE INC. | $15.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $125.00 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124901423 | CMS |
| Abbott Laboratories | $150.00 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124901425 | CMS |
| ABBVIE INC. | $15.32 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997367 | CMS |
| Amgen Inc. | $125.00 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117372031 | CMS |
| Amgen Inc. | $28.57 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117372025 | CMS |
| Amgen Inc. | $125.00 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111695208 | CMS |
| Amgen Inc. | $27.64 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117372027 | CMS |
| Amgen Inc. | $25.64 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117372029 | CMS |
| Astellas Pharma US Inc | $90.00 | 01/10/2024 | Education | Undisputed | 01/23/2026 | 1139385516 | CMS |
| Astellas Pharma US Inc | $79.99 | 02/07/2024 | Education | Undisputed | 01/23/2026 | 1139343146 | CMS |
| Novartis Pharmaceuticals Corporation | $34.21 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087340493 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.